The McClelland Lab
@DrMcClellandLab
Followers
188
Following
742
Media
105
Statuses
396
Our @NIH-funded mission: To tangibly foster cancer-killing #RadOnc access equity regardless of race, ethnicity, gender or socioeconomic status. PI @TheDrWood
Joined March 2022
Hearty congratulations to @OUCollegeofMed MS4 Jared Gregston for his #ASCOQLTY25 Merit Award! Continuing our lab’s proud #ASCOQLTY award-winning tradition; our 4th Merit Award in the past 4 years!.@TomiwaAwobayiku .@Ify_Ekpunobi .@UlyssesG_MD .#RadOnc.#RepresentationMatters
Congratulations to the recipients of the 2025 Quality Care Symposium Merit Awards. Each of the 42 oncology professionals are recognized for their respective field and research advancements within the cancer care community. See the list: @ASCO #ASCOQLTY25
0
1
5
Congratulations to the most recent recipients of our traditional #TheMcClellandLabMug celebratory gift for publishing their 1st peer-reviewed first-authored lab manuscripts: stud members Kamryn Davis, Nimisha Kasliwal, @MayaJanel, & Jared Gregston! Great work…who’s next? #RadOnc
1
2
10
RT @TheDrWood: Well-deserved congratulations to awesome mentee & @DrMcClellandLab member Dante Sanders (@UofSCSOMC MS4) for winning an @AST….
0
3
0
#21.(PMID 40742876).
pubmed.ncbi.nlm.nih.gov
Over 60% of participants in this study experienced some degree of meaningful FT. These results from an ongoing phase I clinical trial indicate a subsection of patients may benefit from proactive...
Hearty congratulations to excellent mentee & MS2 @MayaJanel for first-authoring work in the @DrMcClellandLab assessing the impact of pre-adjuvant #RadOnc chemotherapy on #FinancialToxicity in early-stage #BreastCancer on the ongoing #NAVAH Phase I trial!.
0
0
0
#20.(PMID 40742311).
pubmed.ncbi.nlm.nih.gov
Navigator-Assisted Hypofractionation Program Survey Validation for African American Breast Cancer Patients
The validation of our Navigator-Assisted Hypofractionation (#NAVAH) survey instrument has been published! Grateful to the Make Cleveland Better @NCBFchurch community outreach initiative & the hard work of several lab members in bringing this to fruition!.
1
0
0
#19.(PMID 40657986).
pubmed.ncbi.nlm.nih.gov
Our retrospective cohort study found significantly lower survey response rates among URMs, which could indicate barriers to sharing patient experiences. These findings establish a baseline for...
Kudos to the awesome @OUHealth team of Dr. Kolton Kardokus, Kerry Stark & Dr. @anhbl9 for leading & shepherding the @DrMcClellandLab investigation of #BreastCancer patient experience at @StephensonCC into a published manuscript!.#RadOnc #MedOnc #bcsm.
1
0
0
#18.(PMID 40643413).
pubmed.ncbi.nlm.nih.gov
These initial findings from the NAVAH program underscore the persistent challenges faced by Hispanic-American cancer patients, particularly in the realms of perceived discrimination and financial...
Huge congratulations to mentee & @DrMcClellandLab member Dr. Maria Lasprilla-Pallares (@Lasp_Maria) for first-authoring our examination of Spanish-language cancer patient care! .#RadOnc.#Match2026.#WomenWhoCurie.#NAVAH.#SiSePuede.#RepresentationMatters.
1
0
0
#17.(PMID 40643400).
pubmed.ncbi.nlm.nih.gov
Most patients diagnosed with breast cancer received treatment, but fewer than half met criteria for GCC. Differences in GCC rate by stage and race suggest both institutional and patient-level...
Well-deserved congrats to stud mentee & @DrMcClellandLab member Jared Gregston (@OUCollegeofMed MS4) for first-authoring our manuscript on care following #BreastCancer dx. He is applying in the upcoming #RadOnc match!.#Match2026.#RepresentationMatters.
1
0
0
The validation of our Navigator-Assisted Hypofractionation (#NAVAH) survey instrument has been published! Grateful to the Make Cleveland Better @NCBFchurch community outreach initiative & the hard work of several lab members in bringing this to fruition!.
0
1
2
#ASCOQLTY25 revealed abstract decisions today! Will soon announce the latest to join our tradition of 3 #ASCOQLTY.@ConquerCancerFd Merit Award winners!.@UlyssesG_MD.@Ify_Ekpunobi.@TomiwaAwobayiku. [Members with non-lab project Merit Awards: @TrishaSantosMD, @Nick_Verdini].#RadOnc
1
0
9
RT @anhbl9: So proud of our team’s recent publication where we investigated the patient experience of breast cancer patients at @Stephenson….
0
4
0
#16.(PMID 40578479).
Grateful to contribute to these newest @ASTRO_org clinical practice guidelines with several giants of #RadOnc, #Neurosurgery, & #NeuroOnc under the leadership of @DYeb_MD!.
1
0
0
#15.(PMID 40525892).
pubmed.ncbi.nlm.nih.gov
As previously published data depicted wide variability, it highlights the need for standardized data collection and reporting practices, as such quantitative data can facilitate the evolution of...
Big congratulations to mentee & @DrMcClellandLab member Dr. Sarojini (Siri) Posani for first-authoring our manuscript examining objective details of postdiagnosis navigator-patient interaction! .#RadOnc.#Match2026.#WomenWhoCurie.#PatientNavigation.#NAVAH.
1
0
0
RT @TheDrWood: Congratulations to precocious mentee & @DrMcClellandLab member Nimisha Kasliwal for scoring a perfect 36 on the ACT! She has….
0
1
0
RT @TheDrWood: “Reporters exposed”.Only after Peter Buxtun’s bravery exposed this study withholding curative penicillin, halting its origin….
pubmed.ncbi.nlm.nih.gov
The Tuskegee Syphilis Study is the longest ethically and morally controversial study in the U.S., mainly based on the lack of respect of the African American race. It disregarded ethical standards...
0
2
0
RT @TheDrWood: Big congrats to stud mentee & @DrMcClellandLab member @MayaJanel for winning the 2025 @NMA_Rads James Collins Best Medical S….
0
1
0
Awesome lab member @Ify_Ekpunobi (MS4) presenting her award-winning work on #RadOnc clinical trials at the 2025 @NMA_Rads James Collins Medical Student & Resident symposium!.#Match2026.#RepresentationMatters.#NMAChicago25
0
1
5
Stud lab member Dante Sanders (MS4) presenting his work with our Navigator-Assisted Hypofractionation (#NAVAH) #ProstateCancer program at the 2025 @NMA_Rads James Collins Medical Student & Resident symposium!.#RadOnc.#Match2026.#pcsm.#RepresentationMatters.#NMAChicago25
0
0
5